Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma—18 months follow-up
- 26 Downloads
The aim of this study is to evaluate the clinical outcomes of micropulse transscleral cyclophotocoagulation (mTSCPC) in cases of refractory glaucoma. Patients with refractory glaucoma were selected to undergo mTSCPC, using the MP3 handpiece from Iridex Laser Systems. Follow-up examinations occurred on a regular basis for 18 months after the procedure. One hundred eyes of 97 patients were treated. Mean pre-laser intraocular pressure (IOP) was 39.14 ± 13.84 mmHg. This was reduced significantly to 22.77.8 ± 10.48 mmHg (41.82% reduction; p < 0.001) at week 1. At months 1, 3, 6, 12, and 18 the IOP mean was 23.81 ± 9.44, 24.27 ± 9.17, 23.09 ± 8.47, 22.76 ± 8.14, and 22.77 ± 8.13 mmHg. The success rate at 18 months was the highest 90.91% for the group with IOP below 26 mmHg and the lowest 70.00% for the IOP group 26–30 mmHg. The mean number of anti-glaucoma drops decreased from 2.63 ± 0.87 to 1.78 ± 0.95. The number of treatments performed was 1.26. The pain felt during the procedure was reported as being moderate. No major postoperative complications were noted. Micropulse transscleral cyclophotocoagulation is a non-invasive, repeatable laser procedure that offers both good and stable results in lowering IOP and decreases the use of antiglaucoma medications for up to 18 months.
KeywordsMicropulse transscleral cyclophotocoagulation Refractory glaucoma Intraocular pressure Diode laser
The authors would like to thank Marius Ardelean for statistical analyses.
Compliance with ethical standards
The authors have no conflict of interests and received no funding for this work.
The study was conducted in accordance with the Helsinki Declaration and in line with the “International Standard of Good Clinical Practice (ICH-GCP E6 STEP 4).
The study received the local Ethics Committee approval nr. 1/01.06.2016 and was registered on the” Iranian Registry of Clinical Trials”, with the reference number IRCT20170325033136N2.
One of the inclusion criteria for our study was signed informed consent.
- 7.Mokbel TH (2011) End stage glaucoma. In: Rumelt S (ed) Glaucoma - basic and clinical concepts. IntechOpen, pp 391–400Google Scholar
- 9.Toyos MM, Toyos R (2016) Clinical outcomes of micropulsed transcleral cyclophotocoagulation in moderate to severe glaucoma. J Clin Exp Ophthalmol 7(6):1–3Google Scholar
- 12.R Core Team R (2019) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3–900051–07-0, URL http://www.R-project.org/